Stocks · Technology · Semiconductors
Astera Labs, Inc. Common Stock ALAB
$350.33 -1.71% Close, Oct 2, 2026 · NASDAQ · Market cap $60.05B
Strong growthStrong trendExpensive vs sector
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $1.20B, up 98.5% from a year earlier, slowing from 104.2% a quarter earlier.
- Diluted EPS over the last four quarters was $2.03, up 261.5% year over year.
- Operating margin widened to 22.8% from 7.0% a year earlier.
PromtFinance scores
Each score is a percentile within the Technology sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 4%
- EPS growth (TTM, YoY)Top 8%
- FCF growth (TTM, YoY)Top 38%
- Revenue growth, 3-year CAGRTop 3%
- Revenue growth accelerationBottom 11%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 15%
- Gross marginTop 19%
- Operating marginTop 13%
- Cash conversion (OCF / net income)Bottom 16%
- Accruals (lower is better)Bottom 11%
- Net debt / EBITDA (lower is better)Top 37%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 44%
- Free-cash-flow yieldBottom 30%
- EBITDA / enterprise valueBottom 32%
- Sales / enterprise valueBottom 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 25%
- 6-month returnTop 2%
- 1-year return vs S&P 500Top 18%
- Distance from 52-week highTop 50%
- Trend checklist (0–4)Top 18%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 31%
- Consecutive EPS beatsTop 21%
- Share of analysts rating BuyTop 38%
- Upside to consensus price targetBottom 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 13%
- Maximum drawdown, 3 yearsBottom 44%
- Beta vs S&P 500 (lower is better)Bottom 6%
- Net debt / EBITDA (lower is better)Top 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 104.2% | 98.5% | ↓ |
| EPS growth (YoY) | 563.7% | 261.5% | ↓ |
| Gross margin | 75.5% | 75.1% | ↓ |
| Operating margin | 7.0% | 22.8% | ↑ |
| FCF margin | 34.7% | 23.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 98.5% | 104.2% | ↓ | Top 4% |
| EPS growth (TTM, YoY) | 261.5% | 563.7% | ↓ | Top 8% |
| Gross margin | 75.1% | 75.5% | ↓ | Top 19% |
| Operating margin | 22.8% | 7.0% | ↑ | Top 13% |
| Net margin | 30.7% | 16.5% | ↑ | — |
| Free-cash-flow margin | 23.0% | 34.7% | ↓ | — |
| Return on invested capital | 15.5% | — | Top 15% | |
| Revenue growth, 3-year CAGR | 120.2% | — | Top 3% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 0.91×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 1.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 16.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +593.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.33×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.03%
- Shareholder yield
- -0.03%
- Share count change, 1 year
- +2.3%
- Share count change, 3-year CAGR
- +11.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 10
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +16.9%
- Average 2-day reaction, last 8
- +0.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $370.42
- Target vs current price
- +5.7%
- Analysts with a rating
- 18
- Share rating Buy or Strong Buy
- 72%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +15.8% | +12.7% | -1.2% | -7.5% | — |
| May 5, 2026 | +13.6% | +7.2% | +3.0% | +76.8% | +48.9% |
| Feb 10, 2026 | +12.4% | -2.6% | -34.1% | -37.9% | +14.0% |
| Nov 4, 2025 | +25.7% | -6.4% | -9.3% | -25.4% | -21.4% |
| Aug 5, 2025 | +35.8% | -1.7% | +30.1% | +26.3% | +22.0% |
| May 6, 2025 | +16.2% | -1.1% | +11.3% | +31.8% | +89.5% |
| Feb 10, 2025 | +42.3% | +2.0% | -13.3% | -39.1% | -29.5% |
| Nov 4, 2024 | +34.8% | -4.1% | +36.7% | +42.3% | +39.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.80 | $0.69 | +15.8% | $392.4M |
| May 5, 2026 | $0.61 | $0.54 | +13.6% | $308.4M |
| Feb 10, 2026 | $0.58 | $0.52 | +12.4% | $270.6M |
| Nov 4, 2025 | $0.49 | $0.39 | +25.7% | $230.6M |
| Aug 5, 2025 | $0.44 | $0.32 | +35.8% | $191.9M |
| May 6, 2025 | $0.33 | $0.28 | +16.2% | $159.4M |
| Feb 10, 2025 | $0.37 | $0.26 | +42.3% | $141.1M |
| Nov 4, 2024 | $0.23 | $0.17 | +34.8% | $113.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 172.6× | — | — | Bottom 44% |
| P/E (forward) | 87.8× | — | — | — |
| EV / EBITDA | 179.5× | — | — | Bottom 32% |
| EV / Sales | 49.87× | — | — | Bottom 6% |
| Free-cash-flow yield | 0.46% | — | — | Bottom 30% |
| Earnings yield | 0.58% | — | — | Bottom 44% |
P/E over the past five years
Range 106.3× – 318.8× since Mar 31, 2025. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +80.1%
- Earnings per share growth (TTM)
- +261.5%
- Change in P/E multiple
- -49.5%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 10
- Days above the 200-day average
- 121
- 50-day average slope (20 days)
- -7.1%
- 200-day average slope (20 days)
- +7.5%
- Distance from 50-day average
- +13.5%
- Distance from 200-day average
- +45.3%
- RSI (14)
- 58.4
- Relative volume
- 0.98×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 94.9%
- Volatility vs own 5-year history
- 59th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.85
- Correlation with S&P 500
- 0.49
- Current drawdown from 1-year high
- -27.5%
- Maximum drawdown, 3 years
- -63.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 26, 2024 | Apr 4, 2025 | -63.7% | 67 days | 84 days (Aug 6, 2025) |
| Sep 18, 2025 | Mar 30, 2026 | -60.2% | 132 days | 36 days (May 20, 2026) |
| Apr 29, 2024 | Aug 7, 2024 | -57.6% | 69 days | 63 days (Nov 5, 2024) |
| Jun 30, 2026 | Jul 29, 2026 | -48.3% | 20 days | Not yet recovered |
| Mar 25, 2024 | Apr 19, 2024 | -24.1% | 18 days | 5 days (Apr 26, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $60.05B
- P/E (TTM)
- 172.6
- EPS, diluted (TTM)
- $2.03
- Revenue (TTM)
- $1.20B
- 52-week range
- $97.89 – $499.48
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $79.9M | $115.8M | $396.3M | $852.5M |
| Gross profit | $58.7M | $79.8M | $302.7M | $645.3M |
| Operating income | -$60.2M | -$29.5M | -$116.1M | $173.4M |
| Net income | -$58.3M | -$26.3M | -$83.4M | $219.1M |
| EPS (diluted) | -$0.45 | -$0.17 | -$0.64 | $1.22 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $113.1M | $141.1M | $159.4M | $191.9M | $230.6M | $270.6M | $308.4M | $392.4M |
| Net income | -$7.6M | $24.7M | $31.8M | $51.2M | $91.1M | $45.0M | $80.3M | $153.1M |
| EPS (diluted) | -$0.05 | $0.14 | $0.18 | $0.29 | $0.50 | $0.25 | $0.44 | $0.84 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Operating cash flow | -$35.9M | -$12.7M | $136.7M | $319.3M |
| Capital expenditure | -$3.9M | -$2.8M | -$34.2M | -$37.5M |
| Free cash flow | -$39.8M | -$15.5M | $102.4M | $281.8M |
| Dividends paid | $0 | $0 | $0 | $0 |
| Net share buybacks | -$313,000 | -$210,000 | $671.1M | $9.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.25B
- Total assets
- $1.93B
- Total liabilities
- $205.8M
- Total debt
- $0
- Net debt
- -$111.5M
- Shareholders’ equity
- $1.73B
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 8,685,910
- Days to cover
- 2.24
- Change vs previous report
- -3.9%
FINRA short interest, settlement date Sep 15, 2026.